Trial no.:
|
PACTR202204835139290 |
Date of Approval:
|
14/04/2022 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
two modes of mechanical ventilation during cardiac surgery. |
Official scientific title |
RESPIRATORY EFFECTS OF TWO MODES OF VENTILATION DURING CARDIAC SURGERY. |
Brief summary describing the background
and objectives of the trial
|
Postoperative pulmonary complications after cardiac surgeries are frequent with an incidence of 50%. These complications are associated with prolonged ICU and hospital stay which increase the healthcare cost.
There are many pulmonary complications that might happen after cardiac surgeries but atelectasis and pleural effusion are the most common. Atelectasis happens because of intraoperative and postoperative causes. These intraoperative causes include general anesthesia induction, manual compression by the surgeon during left internal mammary artery harvesting and cannulation of IVC, and apnea during cardiopulmonary bypass time.
Mechanical ventilation is a must during cardiac surgeries even during off-pump coronary artery bypass surgery. There are different modes of ventilation but the volume-controlled (VCV) mode is the most widely used mode of ventilation. VCV is delivering more or less the preset Tidal volume (TV) and the preset respiratory rate (RR) associated with increased peak inspiratory pressure and increased risk of volutrauma and barotrauma.
Pressure regulated volume control mode (PRVC) is a new mode of ventilation that gathers the advantage of VCV of delivering adequate TV and the advantage of pressure-controlled ventilation (PCV) of decreasing the peak and the plateau airway pressures. It is characterized by a decelerating flow that can achieve proper alveolar ventilation and oxygenation. PRVC mode is calculating the lung compliance after each breath and delivers the preset TV with the lowest possible inspiratory pressure.
The aim of this prospective randomized study is to compare the effects of PRVC and VCV on oxygenation (measured by oxygenation index, OI) as the primary outcome and on respiratory dynamics as the secondary outcome.
We hypothesize that PRVC will be associated with a better oxygenation index and respiratory dynamics.
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Anaesthesia |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Devices |
Anticipated trial start date |
15/05/2022 |
Actual trial start date |
|
Anticipated date of last follow up |
15/11/2022 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
62 |
Actual target sample size (number of participants) |
|
Recruitment status |
Not yet recruiting |
Publication URL |
|
|